Hazlett, Burt & Watson’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $277K | Sell |
6,003
-425
| -7% | -$19.6K | 0.11% | 165 |
|
|
2025
Q1 | $392K | Sell |
6,428
-21
| -0.3% | -$1.28K | 0.18% | 121 |
|
|
2024
Q4 | $362K | Hold |
6,449
| – | – | 0.16% | 131 |
|
|
2024
Q3 | $333K | Sell |
6,449
-374
| -5% | -$19.3K | 0.15% | 145 |
|
|
2024
Q2 | $283K | Sell |
6,823
-100
| -1% | -$4.15K | 0.15% | 144 |
|
|
2024
Q1 | $375K | Sell |
6,923
-1,384
| -17% | -$75K | 0.22% | 96 |
|
|
2023
Q4 | $425K | Sell |
8,307
-136
| -2% | -$6.96K | 0.29% | 70 |
|
|
2023
Q3 | $489K | Buy |
8,443
+1
| +0% | +$58 | 0.36% | 54 |
|
|
2023
Q2 | $537K | Buy |
8,442
+38
| +0.5% | +$2.42K | 0.4% | 48 |
|
|
2023
Q1 | $582K | Buy |
8,404
+401
| +5% | +$27.8K | 0.48% | 38 |
|
|
2022
Q4 | $575K | Buy |
8,003
+100
| +1% | +$7.19K | 0.51% | 37 |
|
|
2022
Q3 | $560K | Sell |
7,903
-251
| -3% | -$17.8K | 0.54% | 36 |
|
|
2022
Q2 | $626K | Buy |
8,154
+251
| +3% | +$19.3K | 0.57% | 36 |
|
|
2022
Q1 | $580K | Buy |
+7,903
| New | +$580K | 0.46% | 45 |
|